TAC1 and glioblastoma: Also in a small cohort of nine patients suffering from secondary GBM, treatment with 213Bi-[Thi8,Met(O2)11]-substance P was well tolerated and resulted in median overall survival of 18.6 months after conversion of the primary low grade glioma to grade IV GBM.10